股票/基金 实时行情 股吧

简称:以岭药业 代码:002603


会计年度:2019-06-30收入分布
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计2,984,198,220.26976,083,442.532,008,114,777.7367.29
医药制造业2,984,198,220.26976,083,442.532,008,114,777.7367.29

会计年度:2018-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计4,814,557,822.461,630,824,896.863,183,732,925.6066.13
其他(补充)12,989,778.927,276,009.715,713,769.2143.99
医药制造业4,801,568,043.541,623,548,887.153,178,019,156.3966.19

会计年度:2018-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
合计2,700,291,018.19901,236,903.641,799,054,114.5566.62
其他(补充)3,218,992.991,074,893.002,144,099.9966.61
医药制造业2,697,072,025.20900,162,010.641,796,910,014.5666.62

会计年度:2017-12-31 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
医药制造业4,069,482,208.111,299,532,097.142,769,950,110.9768.07

会计年度:2017-06-30 
项目名称主营业务收入主营业务成本主营业务毛利毛利率
医药制药业2,235,273,283.74711,964,058.231,523,309,225.5168.15

    2/5 转到